Wang et al. (2018) reported that GSDMD inhibits cell proliferation in gastric cancer. Recently, Zheng et al. (2024) demonstrated that CHMP3 could affect the development of liver cancer through caspase-1-mediated pyroptosis. Here, CASP1 is linked to liver cancer.